Cargando…
Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy
Natriuretic peptides (NPs) promote diuresis, natriuresis and vasodilation in early chronic heart failure (CHF), countering renin–angiotensin–aldosterone system (RAAS) and sympathetic nervous system (SNS) overstimulation. Despite dramatic increases in circulating NP concentrations as CHF progresses,...
Autor principal: | Díez, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297869/ https://www.ncbi.nlm.nih.gov/pubmed/27766748 http://dx.doi.org/10.1002/ejhf.656 |
Ejemplares similares
-
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019) -
Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015) -
The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016) -
Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes
por: Cunha, Filipe M., et al.
Publicado: (2017) -
Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure
por: Breidthardt, Tobias, et al.
Publicado: (2022)